ReviewWorld journal of clinical oncology2014
Advances in adjuvant systemic therapy for non-small-cell lung cancer.
Review in World journal of clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Treatment-free survival after discontinuation of immune checkpoint inhibitors in mNSCLC: a systematic review and meta-analysis.Frontiers in immunology · 2023Pooled it
- Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.Oncotarget · 2016Pooled it
- Inhaled Chemotherapy.Journal of aerosol medicine and pulmonary drug delivery · 2025Review
- RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.Oncology letters · 2017Article
- Impact ofMolecular and clinical oncology · 2017Article
- Accounting for tumor purity improves cancer subtype classification from DNA methylation data.Bioinformatics (Oxford, England) · 2017Article
- Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.International journal of nanomedicine · 2017Article
- Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.Evidence-based complementary and alternative medicine : eCAM · 2017Article
- MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer.Oncotarget · 2016Article
- Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.Naunyn-Schmiedeberg's archives of pharmacology · 2015Article
- Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer.Journal of experimental & clinical cancer research : CR · 2015Article
- Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.International journal of clinical and experimental pathology · 2015Article
- Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer.International journal of clinical and experimental pathology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-small-cell lung cancer remains a leading cause of death around the world. For most cases, the only chance of cure comes from resection for localised disease, however relapse rates remain high following surgery. Data has emerged over recent years regarding the utility of adjuvant chemotherapy for improving disease-free and overall survival of patients following curative resection. This paper reviews the clinical trials that have been conducted in this area along with the studies integrating radiation therapy in the adjuvant setting. The role of prognostic gene signatures are reviewed as well as ongoing clinical trials including those incorporating biological or targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.